Showing 1 - 10 of 11
Persistent link: https://www.econbiz.de/10011306461
It is acknowledged that economic evaluation methods as they have been developed for Health Technology Assessment do not capture all the costs and benefits relevant to the assessment of public health interventions. This paper reviews methods that could be employed to measure and value the broader...
Persistent link: https://www.econbiz.de/10009753411
Background: Economic evaluation focuses on Quality-Adjusted-Life-Years (QALYs) as the main valuation method. However, it is well known that factors beyond health related quality of life are important to patients and the public. Whilst discrete-choice-experiments (DCE) have been extensively used...
Persistent link: https://www.econbiz.de/10011586467
Cost-utility analyses undertaken to inform decision making regarding colorectal cancer (CRC) require a set of health state utility values (HSUVs) so that the time CRC patients spend in different health states can be aggregated into quality-adjusted life-years (QALY). This study reviews...
Persistent link: https://www.econbiz.de/10011586610
Persistent link: https://www.econbiz.de/10012491007
Persistent link: https://www.econbiz.de/10014565325
Persistent link: https://www.econbiz.de/10014427193
In a wide range of health care jurisdictions, to give priority to the severely ill over the less severely ill is important in decisions about resource allocation across patient groups. We summarise data on concerns for severity measured at a cardinal level in preference studies in various...
Persistent link: https://www.econbiz.de/10010776772
Aims: This paper briefly reviews the theoretical and empirical foundation for the economic valuation of preventing fatalities, referred to as the value of a statistical life (VSL), and summarizes recent published empirical evidence on VSL in Sweden. <P> Methods: Literature searches were conducted...</p>
Persistent link: https://www.econbiz.de/10008682860
Recent focus on cost-benefit/socio-economic assessment of government “life-saving” programmes within public health, pharmaceutics, transport, and civil contingencies has spurred a wave of empirical research on the value of a statistical life (VSL) in Sweden. This paper provides an overview...
Persistent link: https://www.econbiz.de/10011048305